Evidence map›Paper›PMID 1327338›Full record

ArticleGlycoconjugate journal1992

Binding receptors for alpha-L-fucosidase in human B-lymphoid cell lines.

R A Dicioccio, A L Miller

Abstract read
PubMed Publisher
In one paragraph

Article in Glycoconjugate journal, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

R A DicioccioDepartment of Gynaecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263.
A L Miller
Roswell Park Comprehensive Cancer Center · USUniversity of California, San Diego · US

Funding

REGULATION OF ALPHA-L-FUCOSIDASE IN HEALTH AND DISEASER01DK032161 · NIDDK · ROSWELL PARK CANCER INSTITUTE · PI DI CIOCCIO, RICHARD A · 1986 to 1993
–
I-CELL DISEASE AND MENTAL RETARDATIONR01NS012138 · NINDS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI MILLER, ARNOLD L · 1985 to 1995
–
NIDDK NIH HHS DK32161NINDS NIH HHS NS12138
6 · The paper itself

Abstract

An established mechanism for directing newly made acid hydrolases to lysosomes involves acquisition of mannose 6-phosphate residues by the carbohydrate portion of acid hydrolases followed by binding to specific membrane-bound transport receptors and delivery to lysosomes. Two distinct phosphomannosyl receptors (CI-MPR and CD-MPR) have been identified. Alternative mechanisms for trafficking acid hydrolases exist. This report examines means for the possible receptor-mediated intracellular transport of alpha-L- fucosidase in lymphoid cells. The binding of alpha-L-fucosidase to intact cells and to total cell membrane preparations, in conjunction with immunoassays of solubilized membrane preparations, revealed the presence of CI-MPR and CD-MPR on human lymphoid and fibroblast cell lines. The mean level of CD-MPR in nine lymphoid cell lines was 7.2-fold greater than CI-MPR. The mean level of CI-MPR in two fibroblast lines was 3.8-fold greater than CD-MPR. The mean content of CI-MPR was 19.5-fold greater in the fibroblasts than in the lymphoid cells. The CD-MPR content of fibroblasts and lymphoid cells was nearly equivalent. Among these cell lines were a fibroblast and a lymphoid line from the same individual. These results indicate that human B-lymphoid cells are deficient in CI-MPR and suggest that modulation of expression of CI-MPR and CD-MPR in lymphoid cells differs from that in fibroblasts, including cell lines with identical genomes. No specific receptor capable of binding alpha-L-fucosidase independent of mannose 6-phosphate was demonstrable, despite published results that support the existence of a mannose 6-phosphate independent trafficking mechanism in lymphoid cells for this enzyme.

Indexed as

Carrier ProteinsReceptors, Cytoplasmic and Nuclearalpha-L-FucosidaseB-LymphocytesCell LineCell MembraneHumansImmunoassayMucolipidosesReceptor, IGF Type 2Receptors, Cell SurfaceReference Valuesalpha-L-FucosidaseCarrier Proteinscation-dependent mannose-6-phosphate receptorReceptor, IGF Type 2Receptors, Cell SurfaceReceptors, Cytoplasmic and Nuclear

Identifiers

PMID1327338
OpenAlexW2051975968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.